Quarterly Earnings

As Black Diamond readies its Q1 2026 report, investors eye gains from a booming energy market and the strategic expansion of its LodgeLink platform.

The frac sand supplier's special dividend highlights a strong balance sheet and a dual-market strategy, but how does it stack up in a competitive field?

Mobile game maker DarkIris pivots to an AI-first strategy, launching an R&D hub in Singapore to build a pan-entertainment AGI content platform.

Enterprise Products Partners raises its distribution and buys back shares, showcasing financial strength ahead of key industry and earnings forecasts.

As Crocs sets its Q1 earnings call, all eyes are on the struggling HEYDUDE brand, contrasting with the core brand's strong international performance.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

As Option Care Health preps its Q1 results, investors watch if it can seize market share from a retreating rival while navigating major biosimilar headwinds.

ADP's latest dividend declaration highlights its financial strength and commitment to shareholders, cementing its status as a reliable income-generating stock.

With stellar trial data for its cholesterol drug obicetrapib, NewAmsterdam Pharma faces investors as it navigates a competitive market and awaits key results.

As Cincinnati Financial preps its Q1 2026 results, we dive into the key metrics and industry trends that will define its performance and market reaction.

Beasley Broadcast Group reports a staggering $190M Q4 loss after a massive asset write-down, but a major debt cut and digital growth signal a fight for survival.

The Norwegian tech firm is shifting its business model with a new platform designed to tame complex, multi-vendor environments and drive recurring revenue.

With a massive $750M boost to its share buyback, Nutanix underscores its financial strength and bets on its future in hybrid multicloud and enterprise AI.

The revolving sushi chain posts strong sales and narrows losses, proving its automation and expansion strategy is paying off despite economic pressures.

Facing a shareholder revolt after a damning indictment, Supermicro launches a major probe into a $2.5B shadow trade scheme. Is it too little, too late?

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

With its lead cancer drug advancing and a strong balance sheet, Nurix will detail its vision for protein degradation at a key investor conference.

A new report reveals a major education gap in obesity care. Informed patients are now demanding options beyond blockbuster drugs like Wegovy and Zepbound.

As Molson Coors preps its Q1 2026 earnings call, all eyes are on its strategy to combat declining volumes and rising costs in a pivotal "reset year."

Outset Medical appoints Derick Elliott as commercial EVP, a strategic move to accelerate its Tablo dialysis system and capitalize on the hospital insourcing trend.